EVOK Evoke Pharma Inc

Nasdaq evokepharma.com


$ 4.65 $ 0.00 (0 %)    

Thursday, 16-Oct-2025 06:03:02 EDT
QQQ $ 605.09 $ 0.00 (0 %)
DIA $ 464.35 $ 0.00 (0 %)
SPY $ 667.33 $ 0.00 (0 %)
TLT $ 90.94 $ 0.00 (0 %)
GLD $ 389.98 $ 0.00 (0 %)
$ 4.71
$ 4.71
$ 4.65 x 39
$ 4.85 x 300
-- - --
$ 1.94 - $ 12.32
23,689
na
7.34M
$ 0.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-13-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 03-21-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-08-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-12-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-06-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-07-2018 12-31-2017 10-K
33 11-14-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-15-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-15-2016 06-30-2016 10-Q
39 05-11-2016 03-31-2016 10-Q
40 03-10-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 5-healthcare-stocks-on-fire-this-week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

Core News & Articles

WMT: -4% | Walmart shares are trading lower following mixed Q2 financial results. APM: 69% | DiamiR's APOE Genotyping Test ...

 evoke-pharma-q2-eps-062-misses-030-estimate-sales-3752m-miss-3796m-estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.30...

 evoke-pharma-secures-new-us-patent-for-gimoti-nasal-spray-targeting-moderate-to-severe-gastroparesis

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

 evoke-pharma-evok-shares-skyrocket-on-new-patent-whats-going-on

Shares of Evoke Pharma are trading sharply higher Wednesday morning. The specialty pharma company received a U.S. Patent Office...

 evoke-pharma-receives-notice-of-allowance-from-uspto-for-us-patent-application-covering-use-of-gimoti-in-patients-with-moderate-to-severe-symptoms-of-gastroparesis

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

 evoke-pharma-q1-eps-051-misses-033-estimate-sales-308m-miss-332m-estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.33...

 evoke-pharma-q4-sales-331m-beat-308m-estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly sales of $3.31 million which beat the analyst consensus estimate of $3.08 million...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION